Detalhe da pesquisa
1.
SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination.
Eur J Immunol
; 52(7): 1194-1197, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35389515
2.
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Ann Hematol
; 100(4): 959-968, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33191481
3.
Erythrocyte depletion from bone marrow: performance evaluation after 50 clinical-scale depletions with Spectra Optia BMC.
J Transl Med
; 15(1): 174, 2017 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28800741
4.
Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Ann Hematol
; 100(8): 2141-2142, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34160650
5.
Management of Patients Undergoing CAR-T Cell Therapy in Germany.
Oncol Res Treat
; 47(3): 65-75, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38198763
6.
Mismatched unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for high-risk acute myeloid leukemia.
Ann Hematol
; 95(6): 1023-5, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27056199
7.
Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19.
Bone Marrow Transplant
; 57(7): 1180-1182, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35444233